glp-3 retatrutide (GLP-3) – Y&P Labs Triple G pen 20 mg

iv therapy

GLP-1 medications offer meaningful benefits, from significant weight loss to improved blood sugar and cardiovascular health

Rare but notable risks include pancreatitis, gallbladder events, and a theoretical concern regarding thyroid C-cell tumors observed in animal studies

The UK medicines regulator, the MHRA, has updated the product information for healthcare professionals and patients regarding the "small risk of severe acute pancreatitis in patients taking GLP-1s." While rare, the sheer scale of GLP-1 use in the UK with one recent study suggesting 1.6 million adults had used them in the last 12 months, and 3.3 million were interested in trying them in the following year makes it important for clinicians and patients to be aware of the warning signs of pancreatitis, said the regulator

I still believe health cannot be judged by body size

Molecules (2021) 26(2):293